135 related articles for article (PubMed ID: 19480415)
21. Targeted radiotherapy of prostate cancer with a gastrin-releasing peptide receptor antagonist is effective as monotherapy and in combination with rapamycin.
Dumont RA; Tamma M; Braun F; Borkowski S; Reubi JC; Maecke H; Weber WA; Mansi R
J Nucl Med; 2013 May; 54(5):762-9. PubMed ID: 23492884
[TBL] [Abstract][Full Text] [Related]
22. Stability Evaluation and Stabilization of a Gastrin-Releasing Peptide Receptor (GRPR) Targeting Imaging Pharmaceutical.
Ghosh A; Woolum K; Kothandaraman S; Tweedle MF; Kumar K
Molecules; 2019 Aug; 24(16):. PubMed ID: 31398865
[TBL] [Abstract][Full Text] [Related]
23. The metabolism of BW2258U89, a GRP receptor antagonist.
Marquez C; Treston A; Moody E; Jakowlew S; Moody TW
Neuropeptides; 2000 Apr; 34(2):108-15. PubMed ID: 10985927
[TBL] [Abstract][Full Text] [Related]
24. Metabolites of [(14)C]-5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3, 6-tetrahydropyridine in mice, rats, dogs, and humans.
Christensen EB; Andersen JB; Pedersen H; Jensen KG; Dalgaard L
Drug Metab Dispos; 1999 Nov; 27(11):1341-9. PubMed ID: 10534320
[TBL] [Abstract][Full Text] [Related]
25. Heterobivalent dual-target probe for targeting GRP and Y1 receptors on tumor cells.
Shrivastava A; Wang SH; Raju N; Gierach I; Ding H; Tweedle MF
Bioorg Med Chem Lett; 2013 Feb; 23(3):687-92. PubMed ID: 23265893
[TBL] [Abstract][Full Text] [Related]
26. Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core.
García Garayoa E; Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwe DA; Schibli R; Schubiger PA
Bioconjug Chem; 2008 Dec; 19(12):2409-16. PubMed ID: 18998719
[TBL] [Abstract][Full Text] [Related]
27. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications.
Fleischmann A; Waser B; Reubi JC
Endocr Relat Cancer; 2009 Jun; 16(2):623-33. PubMed ID: 19478282
[TBL] [Abstract][Full Text] [Related]
28. Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent.
Chun AW; Cosenza SC; Taft DR; Maniar M
Cancer Chemother Pharmacol; 2009 Dec; 65(1):177-86. PubMed ID: 19466411
[TBL] [Abstract][Full Text] [Related]
29. Distribution, metabolism and excretion of a synthetic androgen 7alpha-methyl-19-nortestosterone, a potential male-contraceptive.
Prasad PV; Arumugam R; Willman M; Ge RS; Sitruk-Ware R; Kumar N
Steroids; 2009 Jan; 74(1):121-31. PubMed ID: 18992267
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of the anticoagulant peptide, MDL 28,050, in rats.
Knadler MP; Ackermann BL; Coutant JE; Hurst GH
Drug Metab Dispos; 1992; 20(1):89-95. PubMed ID: 1347003
[TBL] [Abstract][Full Text] [Related]
31. Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.
von Guggenberg E; Sallegger W; Helbok A; Ocak M; King R; Mather SJ; Decristoforo C
J Med Chem; 2009 Aug; 52(15):4786-93. PubMed ID: 19591486
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.
Lucatelli C; Honer M; Salazar JF; Ross TL; Schubiger PA; Ametamey SM
Nucl Med Biol; 2009 Aug; 36(6):613-22. PubMed ID: 19647167
[TBL] [Abstract][Full Text] [Related]
33. Metabolism and cytotoxic effects of T-2 toxin and its metabolites on human cells in primary culture.
Königs M; Mulac D; Schwerdt G; Gekle M; Humpf HU
Toxicology; 2009 Apr; 258(2-3):106-15. PubMed ID: 19428930
[TBL] [Abstract][Full Text] [Related]
34. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
[TBL] [Abstract][Full Text] [Related]
35. In vivo and in vitro metabolism of 5-deazaacyclotetrahydrofolate, an acyclic tetrahydrofolate analogue.
Hanlon MH; Ferone R; Mullin RJ; Keith BR
Cancer Res; 1990 Jun; 50(11):3207-11. PubMed ID: 2334916
[TBL] [Abstract][Full Text] [Related]
36. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacokinetics of glyprolines (PGP) upon intragastric administration].
Bakaevea ZV; Samonina GE; Andreeva LA; Zolotarev IuA; Kozik VS; Ashmarin IP; Miasoedov NF
Eksp Klin Farmakol; 2004; 67(4):57-60. PubMed ID: 15500050
[TBL] [Abstract][Full Text] [Related]
38. Biodistribution, metabolism, and excretion of radioiodinated phospholipid ether analogs in tumor-bearing rats.
Plotzke KP; Rampy MA; Meyer K; Ruyan M; Fisher SJ; Wahl RL; Skinner RW; Gross MD; Counsell RE
J Nucl Biol Med (1991); 1993 Dec; 37(4):264-72. PubMed ID: 8172971
[TBL] [Abstract][Full Text] [Related]
39. The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3).
Boyle RG; Humphries J; Mitchell T; Showell GA; Apaya R; Iijima H; Shimada H; Arai T; Ueno H; Usui Y; Sakaki T; Wada E; Wada K
J Pept Sci; 2005 Mar; 11(3):136-41. PubMed ID: 15635635
[TBL] [Abstract][Full Text] [Related]
40. Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues.
Schroeder RP; van Weerden WM; Bangma C; Krenning EP; de Jong M
Methods; 2009 Jun; 48(2):200-4. PubMed ID: 19398012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
